arrow
G

George N. Dalekos

ern rare-liver
H指数:27
被引数:4,108

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy

免疫介导性肝损伤中升高的多反应性免疫球蛋白G及对免疫抑制疗法的需求

2026-03-080
OAAI
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trial

29-mRNA宿主反应特征在COVID-19肺炎中区分细菌感染、病毒感染和疾病进展的分类:SAVE-MORE随机临床试验的事后分析

2025-06-300
OAAI
Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial response
2024-11-010
OAAI
Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation
2024-08-230
PRE
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group
2023-10-014
OAAI
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome
2022-06-2367
OA
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

改善原发性胆汁性胆管炎生存率的治疗目标: 治疗目标应是胆红素在正常范围内且碱性磷酸酶正常化

2020-02-2082
OA